Conference Agenda

15th Biosimilars & Biologics Global Congress 2024 Europe

Day 1: Thursday 5th December 2024

Challenges, Trends and Opportunities

Caroline Boulliat, CEO & Founder, Genchrome Limited

  • Performance of latest biosimilars
  • Challenges facing the sector
  • Future Biosimilar Opportunities

Hoori Kaskanian, Global Head Biopharmaceuticals Strategy, Portfolio and BD&L, Sandoz

  • Critical aspects of the global Biosimilar market such as vendor landscape, competitive strategies,
    market drivers and challenges
  • Changing market dynamics within the Biosimilars market
  • What are the recent biosimilar market trends and development to date
  • Useful guidelines for players to understand and define their strategies more efficiently in order to
    keep themselves ahead of their competitors
  • Emerging new ventures who are creating an impact on the global market with their latest innovations
    and technologies.

Moderator: 

Caroline Boulliat, CEO & Founder, Genchrome Limited

Panelist:

Nick Stephens, Executive Chair, The RSA Group

Nico Bacharidis, Member of the Board of Directors, Cube RM

Hoori Kaskanian, Global Head Biopharmaceuticals Strategy, Sandoz

  • The 20-year Biosimilar Journey
  • Learnings from launches
  • Perspectives for the future

Caroline Boulliat, CEO & Founder, Genchrome Limited

(Former Biosimilar Country Manager- Amgen- & Global Team Lead Biosimilar -Pfizer)

  • Opportunities, threats and policy changes that impact the UK market

Mark Samuels, Chief Executive , British Biosimilars Association

 

Innovations, Clinical Considerations and Manufacturing

Rodeina Challand, VP Scientific Affairs, BioFactura, Inc.

  • Opening doors to talent you didn’t know existed
  • Reducing the complexity around building out the right leadership teams
  • Enabling and empowering behaviours that you want to trickle into your business

Kristian Juergensen, Chief Commercial Officer, The RSA Group

Poppy Moore, Senior Consultant, The RSA Group

Sandy Chadwick, Head of Global Marketing, The RSA Group

  • Overview of the Medical Affairs Function, Medical Scientific Liaison roles and responsibilities
  • Background on current pipeline biosimilars portfolio
  • Medical initiatives used to expand knowledge/confidence in use of biosimilar products
  • Bioequivalence studies/interchangeability
  • Personal medical affairs experience in transitioning from originator medicine to biosimilars
  • Examples of case studies in the biosimilar space

 Rajpreet Grewal, Senior Medical Scientific Liaison, Fresenius-Kabi

  • Totality-of-the- evidence principles
  • The value of:
  • – Non-Clinical
  • – PK Trials
  • – Efficacy Trials
  • Future Outlook- US and EU

Rodeina Challand, VP Scientific Affairs, BioFactura, Inc.

  • Challenges and obstacles faced by manufacturers in developing biosimilars
  • How to overcome challenges, increase development success and optimize result
  • Techniques in bringing the next generation of Biosimilars to the market
  • Reducing capital investment and creating cost effective and scalable manufacturing operations

Moderator:

Rodeina Challand, VP Scientific Affairs, BioFactura, Inc.

Panellist:

Xavier Fraise, Principal, F.-X. Frapaise Pharma Consulting, Former VP. Clin Dev. Merck
Rajpreet Grewal, Senior Medical Scientific Liaison, Fresenius-Kabi

Rodeina Challand, VP Scientific Affairs, BioFactura, Inc.

Sponsors & Exhibitors
Day 2 Agenda

Who Attends

The 14th Biosimilars Global Congress 2022 Europe, will provides a unique platform for the convergence of stakeholders in the biosimilars industry to discuss and network with top tier government, hospitals, pharmaceuticals, biopharmaceuticals, non-profit organizations, biosimilar developers as well as regional and local manufacturers. Our event delegates include Chief Executives, Executive Directors, Vice Presidents, Heads, Team Leaders & Managers from a range of organisations including..

AbbVie Canada – Abbvie – Abzena – AGES MEA – Alliance for Safe Biologics – Amgen Inc – Applied Photophysics Ltd – Arecor – Avalere Health – AstraZeneca – Barclays – Bates White – Baxalta Inc – Baxalta US Inc – Baxter Healthcare – Benchworks Inc – Biocad Brazil – Biocad Russia – Bioeq – BioFactura Inc – Biogen Idec – Biogen International GmbH – Biogen – Biologics Consulting Group Inc – BIOMEDICA – BioPharm Insight – Biopharmaspec Inc – BioVirtus – BioWorld Today – Bird and Bird – Boehringer Ingelheim – Bristol Myers Squibb – Caprion – Cardinal Health – Charles River Laboratories – Chatfield Pharmaceuticals Ltd – CIMA Industries SA – Cipla Ltd – Clearside Biomedical – Clinigen CTS – CMC Biologics A/S – COFEPRIS – Consumer Health Forum of Australia – Cook Pharmica LLC – Deutsche Bank – Dr. Reddy’s Laboratories – Drinker Biddle & Reath – Durbin Global – Dyadic International (USA) Inc – EMD Millipore – EMD Serono – ENCB-IPN – Epirus Biopharmaceuticals – Eurofins Lancaster Laboratories – FirstWord – Fresenius Kabi – Fujifilm Diosynth Biotech – Fujifilm Kyowa Kirin Biologics Co. Ltd – GE Healthcare Life Sciences – Genentech – Geolab Pharmaceutical Industry – Glyconex – Granzer Regulatory Consulting & Services – Grupo Farmaceutico Somar – GSK – Hanwha Biologics – Hanwha Chemicals – Harvest Moon Pharmaceuticals – Hospira Inc – IMS Health – Innovent Biologics Inc – Intra – Cellular Therapies Inc – inVentiv Health Clinical – Janssen Inc – JHL Biotech Inc Taiwan – KLJ Associates – Lake Partners – Libbs Farmaceutica – Lifescience Dynamics – Lonza Biologics PLC – Lupin Pharmaceuticals India – mAbXience – Medimmune – Merck & Co – Merck Biosimilars – Merck Millipore – Merck Serono – Merck Sharp & Dome Ltd – Merck – Merckle GmbH – Milliman – MITSUBISHI GAS CHEMICAL COMPANY INC – Momenta Pharmaceuticals Inc – Multipharma – Mylan – Myoderm – Napp Pharmaceuticals – Nippon Kayaku Co Ltd – NIPTE – Norwegian Medicines Agency – Novo Nordisk – Omnicare Pharma GmbH – Orygen Biotechnologica – PARAXEL International – Patheon – PCI Pharma Services – Pfizer Inc – Plexus Ventures Limited – PPD – PRA Health Sciences – PRA International – Probiomed S.A de C.V – Protagen Protein Services GmbH – Qually Corporacion S.A de C.V – Queens University – Ratiopharm – Roche Farmaceutica – Sanape LLC – S &Oz Inc. (a Novartis Company) – Sciex Separations – SciMentum – SGS Group Ltd (USA) – SGS Life Sciences Services – SGS M-Scan Ltd – Shanghai CP Guojian Pharmaceutical Co Ltd – Spectrum Paharmaceuticals – SPL – Stefantech Systems Inc – Sterne Kessler Goldstein & Fox P.L.L.C – Sughrue Mion PLLC USA – Sun Pharmaceuticals Industry Ltd – Taylor Wessing LLP – Teva Pharmaceuticals – Texcell – Therapeutic Proteins International LLC – Toxikon Europe – Transformity – University Alkharh EDU – Virdispharma – Voisin Consulting Life Sciences – West Pharmaceutical Services Inc – Woodley Bio Reg Ltd – Wyatt Health Management – YAKUMED – Ypsomed AG – ZOTEK King Lai Co. Ltd (KunShan)